Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialSteven E. Lipshultz, Steven D. Colan, Rebecca E. Scully et al.|The Lancet Oncology|2010Cited by 452
Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils.R. John Looney, Clark L. Anderson, Daniel H. Ryan et al.|The Journal of Experimental Medicine|1986Cited by 139
Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With DexrazoxaneElly Barry, Lewis B. Silverman, Lynda M. Vrooman et al.|Journal of Clinical Oncology|2008Cited by 119
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M. Vrooman, Stephen E. Sallan, Donna Neuberg et al.|European Journal of Cancer|2011Cited by 117
Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery AneurysmAdriana H. Tremoulet, Jane C. Burns, Feng He et al.|The Journal of Pediatrics|2019Cited by 39